NASDAQ Weekly News Round Up $APRE Aprea Therape
Post# of 5142

$APRE Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119,
Aprea Therapeutics Establishes Recommended Phase 2 Dose (RP2D) for ATRN-119
https://www.globenewswire.com/news-release/20...apies.html
$MYSE Myseum Awarded Israeli Patent for Advanced Digital Privacy Technology
https://www.globenewswire.com/news-release/20...nology.htm
$MYSE Myseum Receives Notice of Patent Allowance for Advanced Digital Privacy Streaming Technology for Secure Video & Audio Communications
https://www.globenewswire.com/news-release/20...tions.html
$RDZN Roadzen Wins Major Auto Insurance Mandate Worth More Than $20 Million in Annual Premiums from One of the World’s Largest Carmakers
https://www.globenewswire.com/news-release/20...akers.html
$RDZN Roadzen’s DrivebuddyAI Secures Six Major E-Commerce Trucking Fleet Clients in Nationwide Rollout Across India
https://www.globenewswire.com/news-release/20...India.html
$PRSO Peraso to Attend and Present at the Planet MicroCap Showcase: Toronto 2025
https://www.accessnewswire.com/newsroom/en/co...ro-1086686
$PRSO Peraso Receives additional Purchase Orders
https://www.accessnewswire.com/newsroom/en/co...-p-1088037
$TOMZ Presenting at the LD Mirco Main Event on Tuesday, October 21st at 10:00 AM PT at the Hotel del Coronado
https://www.newsfilecorp.com/release/269227

